| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $717.8M | — |
| Cost of Revenue | $407.7M | — |
| Gross Profit | $310.1M | — |
| R&D Expense | $30.3M | — |
| SG&A Expense | $362.3M | — |
| Operating Income | -$297.8M | — |
| Pre-tax Income | -$306.6M | — |
| Income Tax | -$18.2M | — |
| Net Income | -$276.9M | -74.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $73.5M | -12.5% |
| Accounts Receivable | $171.2M | +8.8% |
| Inventory | $143.3M | +15.9% |
| Current Assets | $480.6M | +6.0% |
| Total Assets | $2.74B | -12.2% |
| Current Liabilities | $244.3M | +10.5% |
| Long-term Debt | $806.8M | -0.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $39.4M | — |
| Capital Expenditures | $34.2M | — |
| Investing Cash Flow | -$39.5M | — |
| Financing Cash Flow | -$7.0M | — |
| Free Cash Flow | $5.2M | — |
| EPS (Basic) | -$1.53 | — |
| EPS (Diluted) | -$1.53 | — |
| Total Liabilities |
| $1.27B |
| -4.7% |
| Stockholders' Equity | $1.40B | -17.4% |